Define Goals
Determine specific research directions for HLA neoantigen, TCRL, antibody, and CAR epitope prediction using our dual-engine platform.
Analysis Phase
Use the IMMUNE platform and algorithms for high-throughput epitope analysis and validation to ensure accuracy and reliability.
Implementation Phase
Integrate experimental validation and functional optimization to develop targets and antibodies for precision immunotherapy.
Service Directions
JWE is committed to collaborating with partners to advance immune target research and precision therapeutics, moving toward a future of precision medicine.
Our platform is widely applied in immunology, drug screening, and molecular interaction studies, offering standardized systems and reliable high-throughput capabilities to support research institutions and industry.
We provide complete technical documentation and SOPs, including HLA display systems, epitope screening workflows, and customized experiment strategies.
Powered by intelligent management and automated workflows, our platform adapts to diverse experiment demands with rapid data processing and visualized outputs.
We collaborate extensively with leading universities and research institutions, driving innovation in immunology and biotechnology. JWE welcomes more partners to create new research value.
CEO / CSO, Former Stanford Lecturer, PhD from University of Pennsylvania, Tsinghua Bachelor, Yeast Display Patent, International Patent on Narcolepsy Detection
CIO, Partner at IP Law Firm, PhD from Tsinghua, Japan Patent Attorney
COO / Head of R&D, PhD from Peking University, Postdoc at Beihang University, years of T cell therapy mechanism research, experience in clinical filings and translation for TIL and other immune cell therapies
CTO, Postdoctoral researcher at Stanford University, expertise in immunomedicine and cellular molecular biotechnology
CFO, Deputy General Manager at Boercheng, former Head of Recovery Operations at Blue Health, MSc in Finance from Illinois Institute of Technology, dual Bachelor degrees in Economics & Communication from UC Davis
Partners & Clients
JWY partners with leading research institutions and companies worldwide to advance immune target research and precision therapeutics.
微信公众号
佳吾益北京科技有限公司